![Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR) Teva-Aripiprazole Tablets for the treatment of Schizophrenia | Markets Insider Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR) Teva-Aripiprazole Tablets for the treatment of Schizophrenia | Markets Insider](https://mma.prnewswire.com/media/740720/Teva_Canada_Limited_Teva_Canada_Announces_the_Launch_of_a_Generi.jpg)
Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR) Teva-Aripiprazole Tablets for the treatment of Schizophrenia | Markets Insider
![Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | SpringerLink Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-020-01566-w/MediaObjects/12325_2020_1566_Fig3_HTML.png)
Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | SpringerLink
![Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | SpringerLink Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-020-01566-w/MediaObjects/12325_2020_1566_Figa_HTML.png)